Literature DB >> 29084772

HDAC8 regulates long-term hematopoietic stem-cell maintenance under stress by modulating p53 activity.

Wei-Kai Hua1, Jing Qi1, Qi Cai1, Emily Carnahan1, Maria Ayala Ramirez1, Ling Li1, Guido Marcucci1, Ya-Huei Kuo1.   

Abstract

The maintenance and functional integrity of long-term hematopoietic stem cells (LT-HSCs) is critical for lifelong hematopoietic regeneration. Histone deacetylases (HDACs) modulate acetylation of lysine residues, a protein modification important for regulation of numerous biological processes. Here, we show that Hdac8 is most highly expressed in the phenotypic LT-HSC population within the adult hematopoietic hierarchy. Using an Hdac8-floxed allele and a dual-fluorescence Cre reporter allele, largely normal hematopoietic differentiation capacity of Hdac8-deficient cells was observed. However, the frequency of phenotypic LT-HSC population was significantly higher shortly after Hdac8 deletion, and the expansion had shifted to the phenotypic multipotent progenitor population by 1 year. We show that Hdac8-deficient hematopoietic progenitors are compromised in colony-forming cell serial replating in vitro and long-term serial repopulating activity in vivo. Mechanistically, we demonstrate that the HDAC8 protein interacts with the p53 protein and modulates p53 activity via deacetylation. Hdac8-deficient LT-HSCs displayed hyperactivation of p53 and increased apoptosis under genotoxic and hematopoietic stress. Genetic inactivation of p53 reversed the increased apoptosis and elevated expression of proapoptotic targets Noxa and Puma seen in Hdac8-deleted LT-HSCs. Dramatically compromised hematopoietic recovery and increased lethality were seen in Hdac8-deficient mice challenged with serial 5-fluorouracil treatment. This hypersensitivity to hematopoietic ablation was completely rescued by inactivation of p53. Altogether, these results indicate that HDAC8 functions to modulate p53 activity to ensure LT-HSC maintenance and cell survival under stress.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29084772      PMCID: PMC5731083          DOI: 10.1182/blood-2017-03-771386

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

1.  Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis.

Authors:  Roel H Wilting; Eva Yanover; Marinus R Heideman; Heinz Jacobs; James Horner; Jaco van der Torre; Ronald A DePinho; Jan-Hermen Dannenberg
Journal:  EMBO J       Date:  2010-06-22       Impact factor: 11.598

2.  Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis.

Authors:  Marinus R Heideman; Cesare Lancini; Natalie Proost; Eva Yanover; Heinz Jacobs; Jan-Hermen Dannenberg
Journal:  Haematologica       Date:  2014-04-24       Impact factor: 9.941

3.  Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity.

Authors:  Yunyuan V Wang; Mathias Leblanc; Norma Fox; Jian-Hua Mao; Kelsey L Tinkum; Kurt Krummel; Dannielle Engle; David Piwnica-Worms; Helen Piwnica-Worms; Allan Balmain; Kenneth Kaushansky; Geoffrey M Wahl
Journal:  Genes Dev       Date:  2011-07-01       Impact factor: 11.361

4.  Histone deacetylase 8 safeguards the human ever-shorter telomeres 1B (hEST1B) protein from ubiquitin-mediated degradation.

Authors:  Heehyoung Lee; Nilanjan Sengupta; Alejandro Villagra; Natalie Rezai-Zadeh; Edward Seto
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 5.  The p53 tumor suppressor protein regulates hematopoietic stem cell fate.

Authors:  Takashi Asai; Yan Liu; Narae Bae; Stephen D Nimer
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

6.  Cloning and characterization of human histone deacetylase 8.

Authors:  I Van den Wyngaert; W de Vries; A Kremer; J Neefs; P Verhasselt; W H Luyten; S U Kass
Journal:  FEBS Lett       Date:  2000-07-28       Impact factor: 4.124

7.  Potent and Selective Non-hydroxamate Histone Deacetylase 8 Inhibitors.

Authors:  Alexander Kleinschek; Christian Meyners; Eros Digiorgio; Claudio Brancolini; Franz-Josef Meyer-Almes
Journal:  ChemMedChem       Date:  2016-11-09       Impact factor: 3.466

8.  CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice.

Authors:  Qi Cai; Robin Jeannet; Wei-Kai Hua; Guerry J Cook; Bin Zhang; Jing Qi; Hongjun Liu; Ling Li; Ching-Cheng Chen; Guido Marcucci; Ya-Huei Kuo
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

9.  Alcam regulates long-term hematopoietic stem cell engraftment and self-renewal.

Authors:  Robin Jeannet; Qi Cai; Hongjun Liu; Hieu Vu; Ya-Huei Kuo
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

10.  Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation.

Authors:  Claire Mazumdar; Ying Shen; Seethu Xavy; Feifei Zhao; Andreas Reinisch; Rui Li; M Ryan Corces; Ryan A Flynn; Jason D Buenrostro; Steven M Chan; Daniel Thomas; Julie L Koenig; Wan-Jen Hong; Howard Y Chang; Ravindra Majeti
Journal:  Cell Stem Cell       Date:  2015-10-22       Impact factor: 24.633

View more
  19 in total

1.  HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3β/Snail signals.

Authors:  Panpan An; Feng Chen; Zihan Li; Yuyi Ling; Yanxi Peng; Haisheng Zhang; Jiexin Li; Zhuojia Chen; Hongsheng Wang
Journal:  Oncogene       Date:  2020-06-04       Impact factor: 9.867

2.  Upregulation of SIRT1 Contributes to dmPGE2-dependent Radioprotection of Hematopoietic Stem Cells.

Authors:  Liqiong Liu; Hongge Li; Andrea M Patterson; P Artur Plett; Carol H Sampson; Khalid S Mohammad; Maegan L Capitano; Pratibha Singh; Chonghua Yao; Christie M Orschell; Louis M Pelus
Journal:  Stem Cell Rev Rep       Date:  2022-03-23       Impact factor: 6.692

3.  CDK19 regulates the proliferation of hematopoietic stem cells and acute myeloid leukemia cells by suppressing p53-mediated transcription of p21.

Authors:  Zihao Zhang; Yukai Lu; Yan Qi; Yang Xu; Song Wang; Fang Chen; Mingqiang Shen; Mo Chen; Naicheng Chen; Lijing Yang; Shilei Chen; Fengchao Wang; Yongping Su; Mengjia Hu; Junping Wang
Journal:  Leukemia       Date:  2022-02-02       Impact factor: 12.883

4.  Isoform-specific involvement of Brpf1 in expansion of adult hematopoietic stem and progenitor cells.

Authors:  Qiuping He; Mengzhi Hong; Jincan He; Weixin Chen; Meng Zhao; Wei Zhao
Journal:  J Mol Cell Biol       Date:  2020-06-11       Impact factor: 6.216

5.  HMGB1-modified mesenchymal stem cells attenuate radiation-induced vascular injury possibly via their high motility and facilitation of endothelial differentiation.

Authors:  Xuan Tao; Mingyang Sun; Min Chen; Rongchao Ying; Wenjie Su; Jian Zhang; Xiaodong Xie; Wei Wei; Xiaohu Meng
Journal:  Stem Cell Res Ther       Date:  2019-03-13       Impact factor: 6.832

6.  p53 modifications: exquisite decorations of the powerful guardian.

Authors:  Yanqing Liu; Omid Tavana; Wei Gu
Journal:  J Mol Cell Biol       Date:  2019-07-19       Impact factor: 6.216

Review 7.  Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer.

Authors:  Matthieu Lacroix; Romain Riscal; Giuseppe Arena; Laetitia Karine Linares; Laurent Le Cam
Journal:  Mol Metab       Date:  2019-10-18       Impact factor: 7.422

8.  Protein arginine methyltransferase 1 is required for maintenance of normal adult hematopoiesis.

Authors:  Lei Zhu; Xin He; Haojie Dong; Jie Sun; Hanying Wang; Yinghui Zhu; Feiteng Huang; Jingying Zou; Zexin Chen; Xiaoying Zhao; Ling Li
Journal:  Int J Biol Sci       Date:  2019-10-23       Impact factor: 6.580

Review 9.  Role of HDACs in normal and malignant hematopoiesis.

Authors:  Pan Wang; Zi Wang; Jing Liu
Journal:  Mol Cancer       Date:  2020-01-07       Impact factor: 27.401

Review 10.  The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.

Authors:  Guo Li; Yuan Tian; Wei-Guo Zhu
Journal:  Front Cell Dev Biol       Date:  2020-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.